ACC: Binge Drinking Further Increases CVD Risk With High Alcohol Consumption
By Lori Solomon HealthDay Reporter
TUESDAY, April 2, 2024 -- High levels of alcohol consumption are associated with increased cardiovascular disease (CVD) risk among men and women aged 65 years and younger, with even higher risk seen among those who also "binge" drink, according to a study presented at the annual meeting of the American College of Cardiology, held from April 6 to 8 in Atlanta.
Jamal S. Rana, M.D., Ph.D., from Kaiser Permanente Northern California in Oakland, and colleagues examined whether or not heavy episodic drinking days (HED; i.e., "binge" drinking), in conjunction with habitual drinking, impacts CVD risk among U.S. adults. The analysis included 697,985 adults (43 percent women) who, in 2014 to 2015, reported drinking alcohol as part of regular health care screening.
The researchers found that for men and women (aged 18 to 65 years), those with high total consumption (≥15 drinks/week for men; eight or more drinks/week for women) had higher odds of CVD compared with those with moderate (three to 14 drinks/week for men; three to seven drinks/week for women) or low (one to two drinks/week for men or women) consumption. Associations were stronger among those reporting any HED (five or more drinks on any day in past three months for men and four or more for women; 20.8 percent). For men older than 65 years, CVD risk was not increased with or without HED. For women older than 65 years and HED, moderate and high total consumptions more than doubled the odds of CVD versus that seen with low consumption.
"Women feel they’re protected against heart disease until they’re older, but this study shows that even when you’re young or middle aged, if you are a heavy alcohol user or binge drink, you are at risk for coronary heart disease," Rana said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted April 2024
Read this next
Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM
FRIDAY, May 31, 2024 -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from...
DNA Methylation-Based Epigenetic Age Mediates Link Between LE8 Score, CVD
WEDNESDAY, May 29, 2024 -- The associations between Life's Essential 8 (LE8) and cardiovascular health are mediated by DNA methylation-based epigenetic age, according to a study...
Semaglutide Boosts Kidney Outcomes With Obesity + Cardiovascular Disease
TUESDAY, May 28, 2024 -- Once-weekly subcutaneous semaglutide shows a benefit for kidney outcomes in people with overweight or obesity and established cardiovascular disease...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.